Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

Circulation. 2024 Jan 16;149(3):270-273. doi: 10.1161/CIRCULATIONAHA.123.064884. Epub 2024 Jan 16.

Christina Canavati^{1

2}, Ahmad Siam³, Sapir Labes^{1

2}, Nirit Trabelsi⁴, Eshcar Regev³, Elchanan Parnasa³, Barhoum Barhoum³, Nur Magadle³, Ofer Perzon³, Maya Braun¹, Hagar Mor-Shaked^{2

5}, Ora Schueler-Furman⁴, Yuval Tabach^{1

2}, Dror Mevorach^{2

3

6}

¹ Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada (C.C., S.L., M.B., Y.T.), Jerusalem, Israel.
² Hebrew University-Hadassah Faculty of Medicine (C.C., S.L., H.M.-S., Y.T., D.M.), Jerusalem, Israel.
³ The Wohl Institute for Translational Medicine (A.S., E.R., E.P., B.B., N.M., O.P., D.M.)., Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
⁴ Department of Microbiology and Molecular Genetics, IMRIC (N.T., O.S.F.), Jerusalem, Israel.
⁵ Department of Genetics, Hadassah Medical Center, Jerusalem, Israel (H.M.-S.).
⁶ Institute of Rheumatology-Immunology-Allergology and Department of Medicine (D.M.), Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

No abstract available

Publication types